• Aletta®
  • Who we serve
  • News
  • About us
Get in touch
  • Aletta® Discover how Aletta performs autonomous blood collection
  • Customer success How we partner with hospitals and labs
Meet Aletta Discover Aletta in real life
  • Laboratory specialists Explore how Aletta supports laboratory workflows
  • Hospital Leadership Explore how Aletta supports your hospital’s innovation strategy
  • Phlebotomists See how Aletta supports staff during routine blood collection
  • Patients What patients can expect from an autonomous blood draw
Meet Aletta Discover Aletta in real life
  • News & Blogs The latest news about Vitestro and Aletta
  • FAQ Answers to common questions about Aletta and Vitestro
Patient punctured by Aletta
Vitestro Receives FDA De Novo Authorization for Aletta®, the World’s First Autonomous Robotic Phlebotomy Device®
  • About Us Learn more about Vitestro and the team
  • Careers Discover your career opportunity at Vitestro
  • Contact Get in touch with us
About Us A team on a mission to redefine diagnostic blood collection
  • Europe
  • USA
  • Rest of the world
  • Aletta®
    • Aletta®
    • Customer success
  • Who we serve
    • Laboratory specialists
    • Hospital Leadership
    • Phlebotomists
    • Patients
  • News
    • News & Blogs
    • FAQ
  • About us
    • About Us
    • Careers
    • Contact
Services Get in touch
  • Europe
  • USA
  • Rest of the world

It appears the content of this website does not support your country.

Vitestro’s website content and availability vary by region. Please visit the website for your country to view the most relevant information.

Subscribe to our newsletter

Europalaan 500 1.N.2
3526 KS Utrecht, Netherlands

LinkedIn
Aletta® About Us News Careers
© Copyright Vitestro 2026 Privacy policy Privacy policy job applicants
© Vitestro 2026 Website by Makepublic & Devbright

Disclaimer: Aletta has received FDA De Novo authorization in the United States and is CE-marked for clinical use in the European Union.